IFP Advisors’s Solid Biosciences SLDB Stock Holding History

IFP Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.16K	Hold	298	–	–	﹤0.01%	4194
2026 Q2	$2.98K	Hold	298	–	–	﹤0.01%	4058
2026 Q1	$2.15K	Hold	298	–	–	﹤0.01%	3936
2025 Q4	$1.68K	Hold	298	–	–	﹤0.01%	3899
2025 Q3	$1.84K	Hold	298	–	–	﹤0.01%	3731
2025 Q2	$1.45K	Buy	298 +290	+3,625%	+$1.02K	﹤0.01%	4041
2025 Q1	$30	Hold	8	–	–	﹤0.01%	4114
2024 Q4	$32	Buy	+8	New	+$44	﹤0.01%	4369

Other funds holding SLDB

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

IFP Advisors's SLDB Position: Q3 2026 in Review

IFP Advisors held its Solid Biosciences (SLDB) position steady in Q3 2026 at 298 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #4194.

IFP Advisors first reported a position in SLDB in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.98K in Q2 2026. 9 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.

IFP Advisors held 298 shares of Solid Biosciences worth $2.16K as of Q3 2026.
IFP Advisors left its Solid Biosciences share count unchanged in Q3 2026.
Solid Biosciences made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4194 holding.
IFP Advisors first reported a position in Solid Biosciences in Q4 2024 and has held it in 8 quarters since.
IFP Advisors's Solid Biosciences position peaked at $2.98K in Q2 2026.
9 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.